Itsa,
With only a skeleton staff, we have no way at all to run an operational product launch globally.
The logistics required to support a drug in market is massive…
The Diamond, George and Nuket can’t do everything…I just don’t see it.
Looking forward to hearing more from the Board on the strategy. I would be highly surprised if Pharma didn’t come on the scene once FDA route is more clear re tox studies.
The Murdoch Institute results are due in next weeks too re new I indications. I gather that is where the Board sees a partnership strategy.
.
$15m cap raise Fresh Equities at 24c, page-168
-
- There are more pages in this discussion • 688 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.32M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 114152 | 7.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 203231 | 1 |
View Market Depth
| Last trade - 08.52am 23/07/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable